The Impact of Lockdown on eBC Mass Concentration over a Semi-arid Region in Southern India: Ground Observation and Model Simulations by Surya Nagi Reddy Palle, Chakradhar Rao Tandule, Raja Obul Reddy Kalluri, Balakrishnaiah Gugamsetty, Rama Gopal Kotalo, Lokeswara Reddy Thotli, Bhavyasree Akkiraju, Siva Sankara Reddy Lingala

Get full text

Peningkatan Performa Pengenalan Wajah pada Gambar Low-Resolution Menggunakan Metode Super-Resolution by Muhammad Imaduddin Abdur Rohim, Auliati Nisa, Muhammad Nurkhoiri Hindratno, Radhiyatul Fajri, Gembong Satrio Wibowanto, Nova Hadi Lestriandoko, Pesigrihastamadya Normakristagaluh

Get full text

STFCropNet: A Spatiotemporal Fusion Network for Crop Classification in Multiresolution Remote Sensing Images by Wei Wu, Yapeng Liu, Kun Li, Haiping Yang, Liao Yang, Zuohui Chen

Get full text

Molecular Detection of Coxiella burnetii in Ticks Isolated from Domestic Animals in Slaughterhouses and Farms, Shahr-E-Rey, Tehran, Iran by Pedram Talaie, Maryam Tavassoli, Ehsan Mostafavi, Zakiyeh Telmadarraiy, Mahdi Rohani, Saber Esmaeili, Mohammad Mehdi Sedaghat

Get full text

Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis by Ce Chen, Jialin Wang, Mengqin Cheng, Haifeng Xie, Wei Li, Chaofeng Zhang

Get full text

CHATGPT: ATTITUDES AND EXPERIENCES OF TECHNICAL UNIVERSITY STUDENTS IN UKRAINE by Oksana Chugai, Kateryna Havrylenko

Get full text

Radioisotope and Metal Concentrations in Borehole Water Samples of Umuahia and Umudike, Nigeria by J.C. Nnaji, O.U. Igwe, K.M. Onyedim, P. Okafor

“…The mean activity concentrations K-40, U-238 and Th-232 had ranges of below detection limit (BDL) – 21.94±2.50 Bq/L; BDL – 7.85 ±1.80 Bq/L and BDL – 5.76 ±0.53 respectively. The SON maximum level for radionuclides in water is 0.1 Bq/L while the WHO limits for U-238 and Th-232 are 10 and 1 Bq/L respectively. …”
Get full text

CB-MNCs@ CS/HEC/GP promote wound healing in aged murine pressure ulcer model by Zhi-cheng Yang, He Lin, Guo-jun Liu, Hui Pan, Jun-lu Zhu, Xiao-hong Zhang, Feng Gao, Zhong Wang, Zhi-hao Wang

Get full text

Phytochemical profile, therapeutic potentials, nutritional composition, and food applications of ginger: a comprehensive review by Great Iruoghene Edo, Ufuoma Augustina Igbuku, Raghda S. Makia, Endurance Fegor Isoje, Tayser Sumer Gaaz, Emad Yousif, Agatha Ngukuran Jikah, Khalid Zainulabdeen, Patrick Othuke Akpoghelie, Rapheal Ajiri Opiti, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Umar

Get full text

EEG-based multivariate and univariate analyses reveal the mechanisms underlying the recognition-based production effect: evidence from mixed-list design by Bohua Zhang, Bohua Zhang, Alhassan Abdullah, Minmin Yan, Yongqing Hou, Antao Chen, Helen McLaren

Get full text

Diabetes mellitus na gestação como fator de risco para complicações neonatais by Marcelo José da Silva de Magalhães, Claudiney Cordeiro Arruda, Iberto Medeiros Cardozo

Get full text

La aplicación de nitrógeno en otoño retrasa la senescencia foliar en manzano (Malus domestica Borkh) by V. DE ANGELIS, E.E. SÁNCHEZ, J.A. TOGNETTI

Get full text

INFLUENCE OF INTEGRATED FINANCIAL MANAGEMENT INFORMATION SYSTEM (IFMIS) ON THE PERFORMANCE OF GOVERNMENT ENTITIES IN NIGERIA by Salaudeen Ibrahim, Abdul-Hakeem Shuaib, Muhammed Basiru Mustapha, Benuh Adama Idris, Tunde Saka Abdulsalam

Get full text

Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability by Huiling Su, Jie Shen, Chenzi Gao, Yue Zhao, Wanyu Deng, Bo Qin, Xin Zhang, Juan Lai, Qian Wang, Jie Dou, Min Guo

Get full text

Translation, cross-cultural adaptation and validation of the composite physical function scale in Chinese community-dwelling older adults by Jiaying Qi, Jing Xu, Hui Zhang, Mingshuai Feng, Hongyan Meng, Li Wang

Get full text

Inferring 3D displacement time series through InSAR measurements and potential field theory in volcanic areas by Andrea Barone, Maurizio Fedi, Antonio Pepe, Pietro Mastro, Pietro Tizzani, Raffaele Castaldo

Get full text

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma by Suzy Van Sanden, Ayman Youssef, Simona Baculea, Keith Stubbs, Spyros Triantos, Zijiao Yuan, Caitlin Daly

“…The MAIC-recalculated hazard ratio (95% credible interval) for erdafitinib vs EV was 0.92 (0.54, 1.57) for overall survival and 0.93 (0.55, 1.56) for progression-free survival, yielding Bayesian probabilities of erdafitinib being better than EV of 62.1% and 60.5%, respectively. For response outcomes, the MAIC-recalculated risk ratio was 1.49 (0.56, 3.90) for confirmed objective response rate and 2.89 (0.27, 30.33) for confirmed complete response with probabilities of 72.6% and 81.3% for erdafitinib being better than EV, respectively. …”
Get full text

From guideline to practice: three years of ICH S11 insights and recommendations by Diana Tavares, Hsiao-Tzu Chien, Hsiao-Tzu Chien, Maria Elzbieta Sheean, Peter Theunissen, Peter Theunissen, Peter van Meer, Peter van Meer, Peter van Meer, Karen Van Malderen

Get full text

Relato de experiência do projeto “Ei, jovem, você entende o que seu corpo fala?” by Fernanda Daniela Dornelas NUNES, Luiz Eduardo de Oliveira Corrêa LIMA, Fernanda Malheiros BARBOSA, Marcela Thaís Gonçalves APARECIDO, Isabela Soares TEX, Isadora Ramos FONSECA, Julia Vitória Gusmão GUIDO, Giovana Dutra MARQUES, Beatriz Gimenez ALVES, Ana Carolina Oliveira FERREIRA, Giovanna Freitas SANTOS

Get full text

Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma by Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu

“…Additionally, the median OS was significantly improved in the combination therapy group compared to the chemotherapy group (11.7 months vs. 6.5 months, P = 0.003). Age and history of radical surgery were significantly associated with OS in patients receiving camrelizumab combined with chemotherapy as second-line treatment (P < 0.05). …”
Get full text